España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Monopar Therapeutics
MNPR
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$17.99
-1.01
-5.32%
Pre-Market: 4:41 AM EDT
Get Report
Comment
Monopar Therapeutics (MNPR) Forecast
News
Earnings
Monopar Therapeutics (MNPR) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Monopar Therapeutics (NASDAQ:MNPR) Stock
Monopar Therapeutics Stock (NASDAQ: MNPR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, November 11, 2024
HC Wainwright & Co. Maintains Buy on Monopar ...
Benzinga Newsdesk
Friday, November 08, 2024
Monopar Therapeutics Q3 EPS $(0.37) Beats $(0...
Benzinga Newsdesk
Tuesday, October 29, 2024
Reported Earlier, Monopar Therapeutics Prices...
Benzinga Newsdesk
Monday, October 28, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Monopar Therapeutics shares are trading lower...
Benzinga Newsdesk
Monopar Therapeutics Announces Proposed Publi...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Friday, October 25, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
What's Going On With Monopar Therapeutics Shares Friday?
Dylan Berman
Monopar Therapeutics shares are trading lower...
Benzinga Newsdesk
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monopar Therapeutics, Intellia Therapeutics, Capri Holdings, Western Digital, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Benzinga Neuro
Thursday, October 24, 2024
Monopar Therapeutics Stock Jumps 4X, Inks Licensing Pact With AstraZeneca For Once Terminated Phase 3 Candidate For Rare Genetic Disorder
Vandana Singh
Monopar Therapeutics Shares Resume Trade Then...
Benzinga Newsdesk
Monopar Therapeutics Shares Resume Trade Then...
Benzinga Newsdesk
Monopar Therapeutics Shares Resume Trade Then...
Benzinga Newsdesk
Monopar Therapeutics Shares Resume Trade Then...
Benzinga Newsdesk
Monopar Therapeutics Shares Halted On Circuit...
Benzinga Newsdesk
Monopar Therapeutics Shares Halted On Circuit...
Benzinga Newsdesk
Monopar Therapeutics Shares Resumes Trade
Benzinga Newsdesk
Monopar Therapeutics Shares Halted On Circuit...
Benzinga Newsdesk
Monopar Therapeutics Shares Resume Trading
Benzinga Newsdesk
Monopar Therapeutics Shares Resume Trade Then...
Benzinga Newsdesk
Monopar Therapeutics Shares Halted On Circuit...
Benzinga Newsdesk
Monopar Therapeutics Shares Resume Trade
Benzinga Newsdesk
Monopar Therapeutics Shares Halted On Circuit...
Benzinga Newsdesk
Monopar Therapeutics shares are trading highe...
Benzinga Newsdesk
Monopar Therapeutics Has Entered Into An Agre...
Benzinga Newsdesk
Tuesday, October 22, 2024
Monopar Presents Encouraging Human Clinical D...
Benzinga Newsdesk
Tuesday, October 15, 2024
Monopar Expands Radiopharma Intellectual Prop...
Benzinga Newsdesk
Friday, October 11, 2024
Monopar Therapeutics shares are trading highe...
Benzinga Newsdesk
Rodman & Renshaw Initiates Coverage On Monopa...
Benzinga Newsdesk
Monday, October 07, 2024
Monopar Therapeutics shares trading higher af...
Benzinga Newsdesk
Monopar Initiates Phase 1a Clinical Trial Of ...
Benzinga Newsdesk
Tuesday, October 01, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Wednesday, September 25, 2024
Monopar Therapeutics Shares Resume Trade Foll...
Benzinga Newsdesk
Thursday, September 12, 2024
Why Monopar Therapeutics (MNPR) Stock Is Skyrocketing Today
Henry Khederian
Monopar Therapeutics shares are trading highe...
Benzinga Newsdesk
Monopar Announces Early Human Clinical Data F...
Benzinga Newsdesk
Tuesday, August 27, 2024
Monopar Receives Notice From Nasdaq That It H...
Benzinga Newsdesk
Wednesday, August 21, 2024
Monopar Therapeutics shares are trading highe...
Benzinga Newsdesk
Monopar Receives Australia Human Research Eth...
Benzinga Newsdesk
Wednesday, August 14, 2024
HC Wainwright & Co. Maintains Buy on Monopar ...
Benzinga Newsdesk
Monopar Therapeutics shares are trading highe...
Benzinga Newsdesk
Monopar Announces Initial Data For First Pati...
Benzinga Newsdesk
Friday, August 09, 2024
Monopar Therapeutics shares are trading lower...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch